Literature DB >> 15722624

Present and future options for the preservation of fertility in female adolescents with cancer.

C C M Beerendonk1, D D M Braat.   

Abstract

Fertility and sexuality are important aspects in the quality of life of long-term survivors of cancer. Adolescents in particular are in a very vulnerable period of their lives with respect to future fertility and sexuality. Special attention should be paid to preserve their fertility whenever possible. The gonadotoxic effect of chemotherapy is largely drug- and dosedependent and is related to age. The effect of radiotherapy is also dependent on dose and age and on the radiation therapy field. The prepubertal ovary is the least susceptible to gonadotoxicity. Ablative regimens for stem cell transplantation have an extremely high risk of ovarian failure. Alternative chemotherapy protocols can reduce long-term gonadotoxicity. Alkylating agents impose the highest risk in causing ovarian failure and should be avoided whenever possible. Up to now, the results of gonadoprotective hormonal therapy have been disappointing and contradictory. Transposition of the ovaries should be considered in each case of planned pelvic or whole body irradiation, where ovarian involvement is unlikely and chemotherapy not necessary. Cryopreservation of preimplantation embryos will seldom be possible in female adolescents due to the lack of a stable relationship with a male partner. Cryopreservation of mature and immature oocytes (necessitating in vitro maturation) is still assumed not to be safe for the offspring. Cryopreservation and transplantation of ovarian tissue seems to be the most promising way of future fertility preservation in female adolescents. At present, it is in its early experimental stage. Its safety and possibilities for fertility preservation in humans are not proven as yet. Additionally, technical and ethical issues need to be addressed. The counseling of female adolescents who are facing the threat of cancer needs careful consideration with regards to the psychosocial impact of the treatment and its consequences. Special attention should be paid to aspects of future quality of life, in particular: fertility and sexuality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722624     DOI: 10.1159/000084101

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  4 in total

Review 1.  Ovarian aging and premature ovarian failure.

Authors:  Yavuz Emre Sükür; Içten Balık Kıvançlı; Batuhan Ozmen
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

Review 2.  Fertility after Cancer: Risks and Successes.

Authors:  Chiara Di Tucci; Giulia Galati; Giulia Mattei; Alessandra Chinè; Alice Fracassi; Ludovico Muzii
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

Review 3.  Pathogenesis and causes of premature ovarian failure: an update.

Authors:  Mahbod Ebrahimi; Firoozeh Akbari Asbagh
Journal:  Int J Fertil Steril       Date:  2011-09-23

Review 4.  Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel's back.

Authors:  Sabahat Rasool; Duru Shah
Journal:  Fertil Res Pract       Date:  2017-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.